By Dr Louise Emmett

Conference Posters

Meijer D; Vis A; Roberts M; Siriwardana A; Morton A; Yaxley J; Samaratunga H; Emmett L; van de Ven P; Heijmans M; Van der Poel H; Donswijk M; Boellaard T; Schoots I; Oprea-Lager D; Coughlin G; van Leeuwen P, 2022, 'MP51-03 DEVELOPMENT OF A NOVEL NOMOGRAM TO IDENTIFY CANDIDATES FOR EXTENDED PELVIC LYMPH-NODE DISSECTION IN PROSTATE CANCER USING MRI AND PSMA PET', Vol. 207, http://dx.doi.org/10.1097/ju.0000000000002626.03

Joshua AM; Stricker P; Epstein RJ; Ho B; Quoc N; Kent R; Willowson KP; Hofman M; Violet JA; Emmett L, 2017, 'Patterns of failure on Ga PSMA (GaPSMA) and F18 FDG (FDG) PET CT in a prospective phase 2 trial of Lu-177 DKFZ PSMA 617 (LuPSMA) in men with castrate resistant metastatic prostate cancer (mCRPC)', IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.2562

Back to profile page